Tatyana V. Tregubchak

Tatyana V. Tregubchak

Auto-generated profile, based on publicly available information

Tatyana V. Tregubchak

State Research Center of Virology and Biotechnology “Vector”, 630559 Kol’tsovo, Russia

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2021 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Open access
PDF file
ARAlexander B Ryzhikov
Alexander B Ryzhikov
EREvgenii А. Ryzhikov
Evgenii А. Ryzhikov
MBMarina P. Bogryantseva
Marina P. Bogryantseva
EDElena D. Danilenko
Elena D. Danilenko
IIIlnaz Ramisovich Imatdinov
Ilnaz Ramisovich Imatdinov
RMRinat A. Maksyutov
Rinat A. Maksyutov
Background. In 2020, the pandemic caused by novel coronavirus infection has become one of the most critical global health challenges during the past century. The lack of a vaccine, as the most effective way to control the novel infection, has prompted the development of a large number of preventive products by the scientific community. We have developed a candidate vaccine (EpiVacCorona) against novel coronavirus infection caused by SARS-CoV-2 that is based on chemically synthesized peptides conjugated to a carrier protein and adsorbed on aluminum hydroxide and studied the specific activity of the developed vaccine. Aims study of the immunogenicity and protectivity of the peptide candidate vaccine EpiVacCorona. Methods. The work was performed using standard molecular biological, virological and histological methods. Results. It was demonstrated that EpiVacCorona, when administered twice, spaced 14 days apart, to hamsters, ferrets, and non-human primates (african green monkeys, rhesus macaques) at a dose of 260 g, which is equal to one inoculation dose for humans, induces virus-specific antibodies in 100% of the animals. Experiments in hamsters showed this vaccine to be associated with the dose-dependent immunogenicity. The vaccine was shown to accelerate the elimination of the virus from the upper respiratory tract in ferrets and prevent the development of pneumonia in hamsters and non-human primates following a respiratory challenge with novel coronavirus. Conclusions. The results of a preclinical specific activity study indicate that the use of EpiVacCorona has the potential for human vaccination.

29 July 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NKNatalia P. Kolosova
Natalia P. Kolosova
TITatyana Ilyicheva
Tatyana Ilyicheva
ADAlexey V. Danilenko
Alexey V. Danilenko
JBJulia A. Bulanovich
Julia A. Bulanovich
SSSvetlana V. Svyatchenko
Svetlana V. Svyatchenko
ARAlexander B. Ryzhikov
Alexander B. Ryzhikov
The 2017–2018 influenza epidemic season in Russia was characterized by a relatively low morbidity and mortality. We evaluated herd immunity prior to the 2017–2018 influenza season in hemagglutination inhibition assay, and performed characterization of influenza viruses isolated from severe or fatal influenza cases and from influenza cases in people vaccinated in the fall of 2017. During the 2017–2018 epidemic season, 87 influenza A and B viruses were isolated and viruses of the 75 influenza cases, including selected viral isolates and viruses analyzed directly from the original clinical material, were genetically characterized. The analyzed A(H1N1)pdm09 viruses belonged to clade 6B.1, B/Yamagata-like viruses belonged to clade 3, and B/Victoria-like viruses belonged to clade 1A and they were antigenically similar to the corresponding vaccine strains. A(H3N2) viruses belonged to clade 3C.2a and were difficult to characterize antigenically and the analysis indicated antigenic differences from the corresponding egg-grown vaccine strain. The next generation sequencing revealed the presence of D222/G/N polymorphism in the hemagglutinin gene in 32% of the analyzed A(H1N1)pdm09 lethal cases. This study demonstrated the importance of monitoring D222G/N polymorphism, including detection of minor viral variants with the mutations, in the hemagglutinin gene of A(H1N1)pdm09 for epidemiological surveillance. One strain of influenza virus A(H1N1)pdm09 was resistant to oseltamivir and had the H275Y amino acid substitution in the NA protein. All other isolates were susceptible to NA inhibitors. Prior to the 2017–2018 epidemic season, 67.4 million people were vaccinated, which accounted for 46.6% of the country's population. Just before the epidemic season 33–47% and 24–30% of blood sera samples collected within the territory of Russia showed the presence of protective antibody titers against vaccine strains of influenza A and influenza B/Victoria-like, respectively. Mass vaccination of the population had evidently reduced the severity of the flu epidemic during the 2017–2018 influenza epidemic season in Russia.

5 December 2016 in Epidemiology and Infection
Verified
Journal Article
Closed access
PDF file
APA. Y. Popova
A. Y. Popova
RMR. A. Maksyutov
R. A. Maksyutov
OTOleg Taranov
Oleg Taranov
TTT. V. Tregubchak
T. V. Tregubchak
AZA. V. Zaikovskaya
A. V. Zaikovskaya
VMV. N. Miheev
V. N. Miheev
SUMMARY: We investigated the first laboratory-confirmed human case of cowpox virus infection in Russia since 1991. Phylogenetic studies of haemagglutinin, TNF-α receptor-like protein and thymidine kinase regions showed significant differences with known orthopoxviruses, including unique amino-acid substitutions and deletions. The described cowpox virus strain, taking into account differences, is genetically closely related to strains isolated years ago in the same geographical region (European part of Russia and Finland), which suggests circulation of viral strains with common origin in wild rodents without spread over long distances and appearance in other parts of the world.

30 January 2023 in Viruses
Verified
Journal Article
Open access
PDF file
MSMaria Starchevskaya
Maria Starchevskaya
EKEkaterina Kamanova
Ekaterina Kamanova
YVYuri Vyatkin
Yuri Vyatkin
TTTatyana Tregubchak
Tatyana Tregubchak
TBTatyana Bauer
Tatyana Bauer
DADenis Antonets
Denis Antonets
The Colorado potato beetle (CPB) is one of the most serious insect pests due to its high ecological plasticity and ability to rapidly develop resistance to insecticides. The use of biological insecticides based on viruses is a promising approach to control insect pests, but the information on viruses which infect leaf feeding beetles is scarce. We performed a metagenomic analysis of 297 CPB genomic and transcriptomic samples from the public National Center for Biotechnology Information Sequence Read Archive (NCBI SRA) database. The reads that were not aligned to the reference genome were assembled with metaSPAdes, and 13314 selected contigs were analyzed with BLAST tools. The contigs and non-aligned reads were also analyzed with Kraken2 software. A total of 3137 virus-positive contigs were attributed to different viruses belonging to 6 types, 17 orders, and 32 families, matching over 97 viral species. The annotated sequences can be divided into several groups: those that are homologous to genetic sequences of insect viruses (Adintoviridae, Ascoviridae, Baculoviridae, Dicistroviridae, Chuviridae, Hytrosaviridae, Iflaviridae, Iridoviridae, Nimaviridae, Nudiviridae, Phasmaviridae, Picornaviridae, Polydnaviriformidae, Xinmoviridae etc.), plant viruses (Betaflexiviridae, Bromoviridae, Kitaviridae, Potyviridae), and endogenous retroviral elements (Retroviridae, Metaviridae). Additionally, the full-length genomes and near-full length genome sequences of several viruses were assembled. We also found sequences belonging to Bracoviriform viruses and, for the first time, experimentally validated the presence of bracoviral genetic fragments in the CPB genome. Our work represents the first attempt to discover the viral genetic material in CPB samples, and we hope that further studies will help to identify new viruses to extend the arsenal of biopesticides against CPB.

21 November 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
NKNatalia P. Kolosova
Natalia P. Kolosova
TITatyana Ilyicheva
Tatyana Ilyicheva
VUVasily Unguryan
Vasily Unguryan
ADAlexey Danilenko
Alexey Danilenko
SSSvetlana Svyatchenko
Svetlana Svyatchenko
ARAlexander B Ryzhikov
Alexander B Ryzhikov
The circulation of seasonal influenza in 2020–2021 around the world was drastically reduced after the start of the COVID-19 pandemic and the implementation of mitigation strategies. The influenza virus circulation reemerged in 2021–2022 with the global spread of the new genetic clade 3C.2a1b.2a.2 of A(H3N2) viruses. The purpose of this study was to characterize influenza viruses in the 2021–2022 season in Russia and to analyze the receptor specificity properties of the 3C.2a1b.2a.2 A(H3N2) viruses. Clinical influenza samples were collected at the local Sanitary-and-Epidemiological Centers of Rospotrebnadzor. Whole genome sequencing was performed using NGS. The receptor specificity of hemagglutinin was evaluated using molecular modeling and bio-layer interferometry. Clinical samples from 854 cases of influenza A and B were studied; A(H3N2) viruses were in the majority of the samples. All genetically studied A(H3N2) viruses belonged to the new genetic clade 3C.2a1b.2a.2. Molecular modeling analysis suggested a higher affinity of hemagglutinin of 3C.2a1b.2a.2. A(H3N2) viruses to the α2,6 human receptor. In vitro analysis using a trisaccharide 6’-Sialyl-N-acetyllactosamine receptor analog did not resolve the differences in the receptor specificity of 3C.2a1b.2a.2 clade viruses from viruses belonging to the 3C.2a1b.2a.1 clade. Further investigation of the A(H3N2) viruses is required for the evaluation of their possible adaptive advantages. Constant monitoring and characterization of influenza are critical for epidemiological analysis.

13 April 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
Vladimir A. TernovoiVladimir A. Ternovoi
Vladimir A. Ternovoi
EPElena Protopopova
Elena Protopopova
ASAlexander N. Shvalov
Alexander N. Shvalov
MKMikhail Yu. Kartashov
Mikhail Yu. Kartashov
RBRoman B. Bayandin
Roman B. Bayandin
APAnna Yu. Popova
Anna Yu. Popova
Kindia tick virus (KITV) is a novel multicomponent virus first detected by direct sequencing of Rhipicephalus geigyi ticks in Guinea in 2017. Here, we present a complete coding genome sequence for all four segments of KITV/2017/1. This virus appears to be evolutionarily related to unclassified flaviviruses, such as Alongshan virus.